0
靶向药易瑞沙的耐药说明!

易瑞沙4.jpg

据印度代购了解,患者服用易瑞沙开始起效以后癌细胞的生长和扩散都会得到有效的控制和缓解,病灶肿瘤由不再继续明显长大而逐步出现缩小的现象,坚持服用易瑞沙可以使对病情的控制得到进一步的巩固和深化,但是在一段时间后病情会突然出现反复,即肿瘤又开始出现增长或发生新的扩散转移就基本可以判定是出现了耐药性,出现耐药性就意味着药物已经对该患者失去作用了。

, according to the Indian act as purchasing agency about patients take Yi Rui sand began to work after cancer cell growth and proliferation can effectively control and mitigate, tumor lesion by no longer continue to significantly grow up gradually, the phenomenon of the narrow, insist on taking Yi Rui sand can make the control of the disease have further consolidate and deepen, but after a period of time the illness would suddenly appear over and over again, When the tumor starts to grow again or has new metastases it's basically drug resistance, and drug resistance means that the drug has lost its effect on the patient.

 

据印度代购了解,易瑞沙的耐药性理论上实在服药6-8个月以后可能会出现,但也是因人而异的。通常来说在患者服用1年左右产生耐药性的患者居多,但也有个别患者服药四五个月就产生了耐药,也有患者在服用易瑞沙两年了还没有产生耐药。所以说耐药性出现的早晚与患者自身的身体机能和病情特殊性有密切的关系。

According to Daigou India, resistance to iressa can theoretically emerge after 6-8 months of medication, but it also varies from person to person. Generally speaking, the majority of patients develop drug resistance after taking the drug for about one year, but some patients develop drug resistance after taking the drug for four or five months, and some patients have not developed drug resistance after taking iressa for two years. Therefore, the emergence of drug resistance sooner or later is closely related to the patient's own physical function and the particularity of the disease.

 


咨询客服
Top